683 Capital Management’s Mereo BioPharma MREO Stock Holding History
Bought
Maintained
Sold
Other funds holding MREO
NM
KCM
683 Capital Management's MREO Position: Q3 2026 in Review
683 Capital Management increased its Mereo BioPharma (MREO) stake by 21% in Q3 2026, buying an estimated $767K and bringing the position to 14,300,000 shares worth $5.75M. The position accounts for 0.24% of the portfolio, ranked #65.
683 Capital Management first reported a position in MREO in Q4 2022 and has held it in 16 quarters since. The position peaked at $19.9M in Q3 2024. 54 funds tracked by Wall St. Rank hold MREO as of Q3 2026.
- 683 Capital Management held 14,300,000 shares of Mereo BioPharma worth $5.75M as of Q3 2026.
- 683 Capital Management bought 2,522,144 Mereo BioPharma shares in Q3 2026, an estimated $767K.
- Mereo BioPharma made up 0.24% of 683 Capital Management's portfolio in Q3 2026, its #65 holding.
- 683 Capital Management first reported a position in Mereo BioPharma in Q4 2022 and has held it in 16 quarters since.
- 683 Capital Management's Mereo BioPharma position peaked at $19.9M in Q3 2024.
- 54 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2026.
Based on 683 Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.